Impact of complications and comorbidities on treatment costs and health-related quality of life of patients with Parkinson's disease

Therapy costs were influenced by disease stage, disease onset as well as present comorbidities. Furthermore, comorbidities such as depression and dementia were diagnosed but were not adequately treated.